140 related articles for article (PubMed ID: 2468957)
1. Effects of the new calcium entry blocker isradipine (PN 200-110) in essential hypertension.
Staessen J; Lijnen P; Fagard R; Hespel P; Tan WP; Devos P; Amery A
J Cardiovasc Pharmacol; 1989 Feb; 13(2):271-6. PubMed ID: 2468957
[TBL] [Abstract][Full Text] [Related]
2. Long-term renal effects of isradipine, a calcium entry blocker, in essential hypertension.
Persson B; Wysocki M; Andersson OK
J Cardiovasc Pharmacol; 1989 Jul; 14(1):22-4. PubMed ID: 2475710
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.
Winer N; Thys-Jacobs S; Kumar R; Davidson WD; Grayson M; Harris C; Walker D; Itskovitz H; Gonasun L
Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist.
Nelson EB; Pool JL; Taylor AA
Clin Pharmacol Ther; 1986 Dec; 40(6):694-7. PubMed ID: 2946507
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension. The British Isradipine Hypertension Group.
Am J Med; 1989 Apr; 86(4A):110-4. PubMed ID: 2523644
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
Kirch W; Burger KJ; Weidinger G; Welzel D
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium antagonist isradipine: a controlled study in middle-aged hypertensive men.
Andersson OK; Persson B; Hedner T; Aurell M; Wysocki M
J Hypertens; 1989 Jun; 7(6):465-9. PubMed ID: 2528578
[TBL] [Abstract][Full Text] [Related]
8. Treatment of essential hypertension with PN 200-110 (isradipine).
Hamilton BP
Am J Cardiol; 1987 Jan; 59(3):141B-145B. PubMed ID: 2949585
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of isradipine in hypertension.
Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindolol.
Hansson L; Dahlof B
Am J Cardiol; 1987 Jan; 59(3):137B-140B. PubMed ID: 2949584
[TBL] [Abstract][Full Text] [Related]
11. Central hemodynamics and brachial artery compliance during therapy with isradipine, a new calcium antagonist.
Andersson OK; Persson B; Widgren BR; Wysocki M
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S87-9. PubMed ID: 1695312
[TBL] [Abstract][Full Text] [Related]
12. A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Isradipine in Hypertension Study Group.
Am J Med; 1989 Apr; 86(4A):119-23. PubMed ID: 2523646
[TBL] [Abstract][Full Text] [Related]
13. The calcium antagonist isradipine in the therapy of hypertension. A double-blind crossover comparison with nifedipine.
Welzel D; Burger KJ
Drugs; 1990; 40 Suppl 2():60-4. PubMed ID: 2150644
[TBL] [Abstract][Full Text] [Related]
14. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
Welzel D; Burger KJ; Weidinger G
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
[TBL] [Abstract][Full Text] [Related]
15. Additive effect of isradipine in combination with captopril in hypertensive patients.
Eggertsen R; Svensson A; Dahlöf B; Hansson L
Am J Med; 1989 Apr; 86(4A):124-6. PubMed ID: 2523647
[TBL] [Abstract][Full Text] [Related]
16. Multicenter evaluation of the safety and efficacy of isradipine in hypertension. The Italian-Belgian Isradipine Study Group.
Am J Med; 1989 Apr; 86(4A):94-7. PubMed ID: 2523664
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive effects of isradipine and captopril as monotherapy or in combination.
Fitscha P; Meisner W; Hitzenberger G
Am J Hypertens; 1991 Feb; 4(2 Pt 2):151S-153S. PubMed ID: 1827007
[TBL] [Abstract][Full Text] [Related]
18. Isradipine (PN 200-110) versus hydrochlorothiazide in mild to moderate hypertension. A multicenter study.
Mohanty PK; Gonasun LM; Goodman RP; Kirkendal WM; Kontos HA; Samuel P; Wright JT
Am J Hypertens; 1988 Jul; 1(3 Pt 3):241S-244S. PubMed ID: 2970853
[TBL] [Abstract][Full Text] [Related]
19. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
Frithz G; Aström B; Dahlöf B; Hansson L; Tollin C; Himanen P; Sundstedt CD
Am J Med; 1989 Apr; 86(4A):115-8. PubMed ID: 2523645
[TBL] [Abstract][Full Text] [Related]
20. An acute dose-response pharmacodynamic evaluation of orally administered isradipine (PN-200-110) in hypertensive patients.
McMahon FG; Vargas R; Ryan JR; Miller H; Faraday S
J Clin Pharmacol; 1988 Jul; 28(7):664-6. PubMed ID: 2975291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]